210 related articles for article (PubMed ID: 31311806)
1. Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells.
Jackson MR; Bavelaar BM; Waghorn PA; Gill MR; El-Sagheer AH; Brown T; Tarsounas M; Vallis KA
Cancer Res; 2019 Sep; 79(18):4627-4637. PubMed ID: 31311806
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides.
Bavelaar BM; Song L; Jackson MR; Able S; Tietz O; Skaripa-Koukelli I; Waghorn PA; Gill MR; Carlisle RC; Tarsounas M; Vallis KA
Mol Pharm; 2021 Oct; 18(10):3820-3831. PubMed ID: 34449222
[TBL] [Abstract][Full Text] [Related]
3. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
4. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
Fu XH; Zhang JS; Zhang N; Zhang YD
World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
[TBL] [Abstract][Full Text] [Related]
5. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy.
Ji XM; Xie CH; Fang MH; Zhou FX; Zhang WJ; Zhang MS; Zhou YF
Acta Pharmacol Sin; 2006 Sep; 27(9):1185-91. PubMed ID: 16923339
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
[TBL] [Abstract][Full Text] [Related]
7. Treating Cancer by Targeting Telomeres and Telomerase.
Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
Qi Z; Mi R
Cancer Gene Ther; 2016 Jan; 23(1):36-42. PubMed ID: 26742579
[TBL] [Abstract][Full Text] [Related]
9. Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.
Zhou JH; Zhang HM; Chen Q; Han DD; Pei F; Zhang LS; Yang DT
World J Gastroenterol; 2003 Aug; 9(8):1808-14. PubMed ID: 12918126
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
[TBL] [Abstract][Full Text] [Related]
11. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
[TBL] [Abstract][Full Text] [Related]
12. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
Kondo Y; Kondo S
Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
[TBL] [Abstract][Full Text] [Related]
13. Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.
Pruzan R; Pongracz K; Gietzen K; Wallweber G; Gryaznov S
Nucleic Acids Res; 2002 Jan; 30(2):559-68. PubMed ID: 11788719
[TBL] [Abstract][Full Text] [Related]
14. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
15. Targeting human telomerase by antisense oligonucleotides and ribozymes.
Folini M; Pennati M; Zaffaroni N
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
[TBL] [Abstract][Full Text] [Related]
17. Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
Zhang P; Xu Q; Chen WT; Duan LQ; Zhang ZY; Zhou XJ
Oral Oncol; 2005 Oct; 41(9):909-15. PubMed ID: 16051514
[TBL] [Abstract][Full Text] [Related]
18. Phosphorothioate‑modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy.
Cao F; Ju X; Chen D; Jiang L; Zhu X; Qing S; Fang F; Shen Y; Jia Z; Zhang H
Mol Med Rep; 2017 Aug; 16(2):2089-2094. PubMed ID: 28627628
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
Iwado E; Daido S; Kondo Y; Kondo S
Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
